Public Interest Groups Back NY AG In Namenda Appeal
By Vin Gurrieri ( February 19, 2015, 6:54 PM EST) -- Patient advocacy and consumer groups urged the Second Circuit on Thursday to keep in place an injunction preventing Actavis PLC from stopping sales of immediate-release Namenda while the New York attorney general pursues an antitrust suit accusing the drugmaker of illegally staving off generic competition....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.